Clostridioides difficile Pyogenic Liver Abscess With an Empyema

WMJ. 2022 Apr;121(1):E5-E9.

Abstract

Introduction: Reports of extraintestinal manifestations of Clostridioides difficile (C difficile) infections are rare. The frequency of these infections comprises approximately 0.17% to 0.6% of all C difficile infections. While they are becoming more frequent worldwide, the precise trend is unclear.

Case presentation: An 83-year-old female patient presented with pleuritic chest pain 2 to 3 months after a needle biopsy of her liver abscess confirmed C difficile. She was found to have extension of the liver abscess into the chest cavity, leading to empyema, and was treated with intravenous antimicrobials.

Discussion: This is the fifth known reported case of C difficile leading to a pyogenic liver abscess and the first case where the C difficile liver abscess was associated with an empyema. While long-term metronidazole is considered effective for managing extra intestinal C difficile infection, our patient was treated with vancomycin and meropenem.

Conclusion: To determine epidemiology and a proper treatment regimen for extraintestinal C difficile infection, a greater accumulation of cases is necessary.

Publication types

  • Case Reports

MeSH terms

  • Aged, 80 and over
  • Anti-Bacterial Agents / therapeutic use
  • Clostridioides
  • Clostridioides difficile*
  • Clostridium Infections* / complications
  • Clostridium Infections* / diagnosis
  • Clostridium Infections* / drug therapy
  • Empyema* / complications
  • Empyema* / drug therapy
  • Female
  • Humans
  • Liver Abscess, Pyogenic* / complications
  • Liver Abscess, Pyogenic* / diagnosis
  • Liver Abscess, Pyogenic* / drug therapy

Substances

  • Anti-Bacterial Agents